secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001104659-24-104667
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell publishes corporate presentation; no material new facts disclosed
--------------------------------------------------------------------------------

- Company released a corporate presentation on October 1, 2024, furnished as Exhibit 99.1.
- Presentation will be available on the investor relations section of the company's website.
- Filing excerpt does not contain specific financial or operational details; content of slide not fully provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924104667/0001104659-24-104667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924104667/tm2425286d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-104667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer